| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1093/GLYCOB/CWI053 |
| P8608 | Fatcat ID | release_ftyzyyxklndc7gj3qaetbboaoy |
| P698 | PubMed publication ID | 15764591 |
| P50 | author | Kevan C Herold | Q87494800 |
| Ann Marie Schmidt | Q89261684 | ||
| P2093 | author name string | Ravichandran Ramasamy | |
| Shi Fang Yan | |||
| Susan J Vannucci | |||
| Shirley Shi Du Yan | |||
| P2860 | cites work | Age-dependent accumulation of advanced glycation end-products in adult Drosophila melanogaster. | Q52563298 |
| A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress. | Q54582355 | ||
| Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases | Q59084980 | ||
| Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways | Q22010208 | ||
| RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides | Q22010236 | ||
| Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis | Q22254188 | ||
| RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease | Q24314906 | ||
| Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection | Q24317377 | ||
| Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily | Q24558912 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| HMG-1 as a late mediator of endotoxin lethality in mice | Q28139166 | ||
| S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE) | Q28184570 | ||
| Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation | Q28187673 | ||
| Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine | Q28189831 | ||
| The S100 family of EF-hand calcium-binding proteins: functions and pathology | Q28284255 | ||
| The S100 protein family: history, function, and expression | Q28293937 | ||
| N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins | Q28378989 | ||
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system | Q28567291 | ||
| Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells | Q28570142 | ||
| High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes | Q28574795 | ||
| N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression | Q28645594 | ||
| Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy | Q29012485 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage | Q29616101 | ||
| S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles | Q29620465 | ||
| Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy | Q30312025 | ||
| In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis | Q31856845 | ||
| Role of advanced glycation end products in aging collagen. A scanning force microscope study. | Q32056302 | ||
| Protein glycation, diabetes, and aging | Q32120059 | ||
| Neurotoxicity of advanced glycation end-products for cultured cortical neurons | Q33181556 | ||
| The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation | Q33853348 | ||
| S100 proteins in Corpora amylacea from normal human brain. | Q33904267 | ||
| How does glucose generate oxidative stress in peripheral nerve? | Q34146338 | ||
| Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy | Q34199766 | ||
| The role of AGEs in aging: causation or correlation | Q34348813 | ||
| Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy | Q34388076 | ||
| Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice | Q34430361 | ||
| Increased risk of type 2 diabetes in Alzheimer disease | Q44745172 | ||
| N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease. | Q44863326 | ||
| Evidence of preferential protein targets for age-related modifications in peripheral blood lymphocytes | Q44972982 | ||
| Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury | Q46535314 | ||
| Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products | Q47231228 | ||
| Advanced glycation end products modulate the maturation and function of peripheral blood dendritic cells | Q47433201 | ||
| High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis | Q47850293 | ||
| Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction | Q47908374 | ||
| Stroke and the risk of Alzheimer disease | Q48115889 | ||
| Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress | Q50180621 | ||
| Hyperinsulinemia and risk of Alzheimer disease. | Q51526824 | ||
| Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice | Q34432623 | ||
| Advanced glycoxidation end products in commonly consumed foods | Q34549688 | ||
| The Maillard hypothesis on aging: time to focus on DNA. | Q34614549 | ||
| Central role of RAGE-dependent neointimal expansion in arterial restenosis | Q34890522 | ||
| The biology of senescence: potential for prevention of disease | Q34993296 | ||
| Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease | Q35039895 | ||
| Glycation products and the pathogenesis of diabetic complications | Q35594899 | ||
| Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress | Q35664175 | ||
| Crosslink breakers: a new approach to cardiovascular therapy | Q35817743 | ||
| Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes | Q35838612 | ||
| Protein glycation: a firm link to endothelial cell dysfunction | Q35857303 | ||
| Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification | Q35877294 | ||
| Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. | Q37308593 | ||
| Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. | Q37363088 | ||
| Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia | Q38292287 | ||
| Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function | Q38422040 | ||
| The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyl | Q39770000 | ||
| RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice | Q40251711 | ||
| Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products | Q40304611 | ||
| Glycation-induced inactivation of NADP(+)-dependent isocitrate dehydrogenase: implications for diabetes and aging | Q40495631 | ||
| Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products | Q40558928 | ||
| Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines | Q40605303 | ||
| Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein | Q40609759 | ||
| Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system | Q40668935 | ||
| Improved arterial compliance by a novel advanced glycation end-product crosslink breaker | Q40684856 | ||
| Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation | Q40712159 | ||
| Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response | Q40899986 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts | Q41045340 | ||
| Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
| Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase | Q41815238 | ||
| RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB | Q41853060 | ||
| Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. | Q41893958 | ||
| The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment | Q42037633 | ||
| RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy | Q42263637 | ||
| Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products | Q42440103 | ||
| N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction | Q42555798 | ||
| Evidence for non-enzymatic glycosylation in Escherichia coli | Q43544090 | ||
| Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. | Q43633661 | ||
| RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response | Q44032299 | ||
| Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. | Q44043194 | ||
| Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease | Q44059260 | ||
| Plasma 3-deoxyglucosone elevation in chronic renal failure is associated with increased aldose reductase in erythrocytes | Q44117979 | ||
| Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain | Q44198123 | ||
| RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. | Q44228474 | ||
| Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia | Q44260190 | ||
| Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients | Q44321459 | ||
| The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control | Q44545480 | ||
| Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death | Q44559324 | ||
| Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration | Q44745040 | ||
| P433 | issue | 7 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 16R-28R | |
| P577 | publication date | 2005-03-10 | |
| P1433 | published in | Glycobiology | Q5572596 |
| P1476 | title | Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation | |
| P478 | volume | 15 |
| Q48274280 | 6-Nitroazolo[1,5-a]pyrimidin-7(4H)-ones as Antidiabetic Agents. |
| Q40516938 | A monoclonal antibody against the receptor for advanced glycation end products attenuates inflammatory and neuropathic pain in the mouse |
| Q38056179 | A review of recent advances and current hypotheses on the pathogenesis of acute laminitis |
| Q64946819 | A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. |
| Q38766433 | AGE-RAGE interaction in the TGFβ2-mediated epithelial to mesenchymal transition of human lens epithelial cells |
| Q36427785 | AGE-RAGE signal generates a specific NF-κB RelA "barcode" that directs collagen I expression |
| Q33886522 | AGEs decrease insulin synthesis in pancreatic β-cell by repressing Pdx-1 protein expression at the post-translational level |
| Q53542852 | Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. |
| Q52091458 | Accumulation of methylglyoxal increases the advanced glycation end-product levels in DRG and contributes to lumbar disk herniation-induced persistent pain. |
| Q46319121 | Activation of AMPK is neuroprotective in the oxidative stress by advanced glycosylation end products in human neural stem cells |
| Q27667822 | Advanced Glycation End Product Recognition by the Receptor for AGEs |
| Q90139165 | Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature |
| Q36578536 | Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice |
| Q59662238 | Advanced Glycation End Products and Risks for Chronic Diseases: Intervening Through Lifestyle Modification |
| Q38254631 | Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain? |
| Q28551744 | Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice |
| Q36915810 | Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food. |
| Q38995799 | Advanced glycation end products (AGE) potentiates cell death in p53 negative cells via upregulaion of NF-kappa B and impairment of autophagy |
| Q41682122 | Advanced glycation end products (AGEs) activate mast cells |
| Q35273098 | Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts |
| Q36996149 | Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs. |
| Q58029351 | Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor |
| Q42180745 | Advanced glycation end products induce endothelial-to-mesenchymal transition via downregulating Sirt 1 and upregulating TGF-β in human endothelial cells |
| Q58805414 | Advanced glycation end products induce neural tube defects through elevating oxidative stress in mice |
| Q33686550 | Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf-2 regulation in vitro |
| Q43720885 | Advanced glycation end products inhibit the expression of collagens type I and III by human gingival fibroblasts |
| Q35093747 | Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer |
| Q36643573 | Advanced glycation end products: Key players in skin aging? |
| Q38405889 | Advanced glycation endproducts in horses with insulin-induced laminitis |
| Q34350918 | Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. |
| Q28570411 | Age-related alterations in retinal neurovascular and inflammatory transcripts |
| Q49210690 | Age-related oxidative changes in pancreatic islets are predominantly located in the vascular system. |
| Q34545820 | Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans |
| Q53763737 | Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9. |
| Q92346511 | Almond-supplemented diet improves sexual functions beyond Phosphodiesterase-5 inhibition in diabetic male rats |
| Q54474275 | Altered bone material properties in HLA-B27 rats include reduced mineral to matrix ratio and altered collagen cross-links. |
| Q52680307 | Ameliorative effects of taurine against diabetes: a review. |
| Q45776839 | Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging |
| Q28581962 | An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease |
| Q43099572 | Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration? |
| Q35881127 | Arg354 in the catalytic centre of bovine liver catalase is protected from methylglyoxal-mediated glycation. |
| Q37315520 | Association of diabetes with amnestic and nonamnestic mild cognitive impairment |
| Q54417809 | Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population. |
| Q45004079 | Association of the glycoxidative stress marker pentosidine with equine laminitis. |
| Q39149192 | Attenuation of Diabetic Conditions by Sida rhombifolia in Moderately Diabetic Rats and Inability to Produce Similar Effects in Severely Diabetic in Rats |
| Q92438095 | Attenuation of diabetic kidney injury in DPP4-deficient rats; role of GLP-1 on the suppression of AGE formation by inducing glyoxalase 1 |
| Q39727356 | Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. |
| Q37266352 | Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats |
| Q92545350 | Brain microstructural abnormalities in type 2 diabetes mellitus: A systematic review of diffusion tensor imaging studies |
| Q64903301 | C. elegans-An Emerging Model to Study Metal-Induced RAGE-Related Pathologies. |
| Q52939905 | CHOP deficiency prevents methylglyoxal-induced myocyte apoptosis and cardiac dysfunction. |
| Q91780151 | Cardiac Autonomic Neuropathy in Diabetes Mellitus |
| Q37598878 | Cardiac autonomic neuropathy in patients with diabetes mellitus. |
| Q40361355 | Cardiovascular dementia - a different perspective |
| Q64271593 | Carnosine improves diabetic retinopathy via the MAPK/ERK pathway |
| Q58723324 | Case-control studies of gene-environment interactions. When a case might not be the case |
| Q37934954 | Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants |
| Q36687957 | Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium |
| Q89551719 | Characterization and Antioxidant Activity of Collagen, Gelatin, and the Derived Peptides from Yellowfin Tuna (Thunnus albacares) Skin |
| Q36431831 | Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. |
| Q41335123 | Characterization of stress and methylglyoxal inducible triose phosphate isomerase (OscTPI) from rice |
| Q40100612 | Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling |
| Q36735682 | Clinical study of advanced glycation end products in egyptian diabetic obese and non-obese patients |
| Q55003432 | Comparative metabolomics of aging in a long-lived bat: Insights into the physiology of extreme longevity. |
| Q52647791 | Conflicting Effects of Methylglyoxal and Potential Significance of miRNAs for Seizure Treatment. |
| Q36458415 | Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat |
| Q38034382 | Corn silk (Stigma maydis) in healthcare: a phytochemical and pharmacological review. |
| Q38261279 | Coumarin derivatives: an updated patent review (2012-2014). |
| Q38150990 | Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention? |
| Q37602130 | Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease |
| Q30575300 | D-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation |
| Q35558632 | DAMPs, ageing, and cancer: The 'DAMP Hypothesis'. |
| Q36724350 | Degradation of functional triose phosphate isomerase protein underlies sugarkill pathology |
| Q38430098 | Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction |
| Q34607563 | Detection of IgE, IgG, IgA and IgM antibodies against raw and processed food antigens |
| Q35053820 | Diabetes and periodontitis |
| Q43039163 | Diabetic maculopathy and retinopathy. Functional and sociomedical significance |
| Q37405521 | Diabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells |
| Q52658260 | Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications. |
| Q33554384 | Diabetic neuropathy: mechanisms to management |
| Q39344658 | Diabetic retinopathy and dysregulated innate immunity |
| Q39427655 | Dietary Advanced Glycation End Products and Cardiometabolic Risk |
| Q33616732 | Dietary Metabolites and Chronic Kidney Disease |
| Q34706565 | Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study |
| Q30484885 | Dissociation of functional status from accrual of CML and RAGE in the aged mouse brain. |
| Q34609989 | Does senescence give rise to disease? |
| Q85893933 | Dual effect of advanced glycation end products in pancreatic islet apoptosis |
| Q40765921 | Effect of Diashis, a polyherbal formulation, in streptozotocin-induced diabetic male albino rats |
| Q57165904 | Effect of a Shoulder Movement Intervention on Joint Mobility, Pain, and Disability in People With Diabetes: A Randomized Controlled Trial |
| Q42547772 | Effect of advanced glycation end products on oxidative stress and senescence of trabecular meshwork cells |
| Q35600704 | Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro |
| Q36495940 | Effect of high advanced glycation end-product diet on pulmonary inflammatory response and pulmonary function following gastric aspiration |
| Q46363812 | Effect of long-term maternal smoking on the offspring's lung health |
| Q46810886 | Effects of insulin combined with idebenone on blood-brain barrier permeability in diabetic rats |
| Q36360786 | Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. |
| Q34987953 | Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study |
| Q38125149 | Exercise and type 1 diabetes (T1DM). |
| Q36826961 | Expression and function of psoriasin (S100A7) and koebnerisin (S100A15) in the brain |
| Q36494499 | Feeding our immune system: impact on metabolism |
| Q50249544 | Formation and elimination of pyrraline in the Maillard reaction in a saccharide-lysine model system |
| Q38258947 | Galectin-3: an emerging all-out player in metabolic disorders and their complications |
| Q51766190 | Gene and protein expression of CXCR4 in adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis undergoing thermal water nasal inhalations. |
| Q34868867 | Glycation and oxidative stress in the failure of dental implants: a case series |
| Q36724696 | Glycation does not modify bovine serum albumin (BSA)-induced reduction of rat aortic relaxation: the response to glycated and nonglycated BSA is lost in metabolic syndrome. |
| Q92017934 | Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention |
| Q39666734 | Glycolaldehyde-modified β-lactoglobulin AGEs are unable to stimulate inflammatory signaling pathways in RAGE-expressing human cell lines |
| Q46665032 | Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model |
| Q38448137 | Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia |
| Q28829321 | Highlighting the impact of aging on type I collagen: label-free investigation using confocal reflectance microscopy and diffuse reflectance spectroscopy in 3D matrix model |
| Q33928779 | Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart. |
| Q37305013 | IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies |
| Q57110548 | Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs) |
| Q39368611 | Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention. |
| Q92820179 | Impact of mesenchymal stem cell senescence on inflammaging |
| Q45893258 | Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE. |
| Q24337632 | In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE) |
| Q42786914 | In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin |
| Q41819713 | Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide |
| Q41539966 | Inhibition and breaking of advanced glycation end-products (AGEs) with bis-2-aminoimidazole derivatives |
| Q38736612 | Inhibition of tumor suppressor p53 preserves glycation-serum induced pancreatic beta-cell demise |
| Q35607690 | Inhibitory effect of Clitoria ternatea flower petal extract on fructose-induced protein glycation and oxidation-dependent damages to albumin in vitro |
| Q46799102 | Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages |
| Q41789363 | Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy |
| Q34728267 | Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies |
| Q84987537 | Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease? |
| Q38004236 | Ischemia-induced hyperglycemia: consequences, neuroendocrine regulation, and a role for RAGE. |
| Q46468830 | Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells |
| Q50993769 | Levetiracetam ameliorates ovarian function in streptozotocin-induced diabetic rats. |
| Q33680171 | Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy Aging |
| Q41367811 | Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis via the mTOR/4E-BP1 signaling pathway |
| Q42089443 | Measurement of Lens Autofluorescence for Diabetes Screening |
| Q80675900 | Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods |
| Q35687287 | Mechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease |
| Q34553052 | Mechanisms of disease: the oxidative stress theory of diabetic neuropathy |
| Q51074865 | Mesenchymal stem cells protects hyperoxia-induced lung injury in newborn rats via inhibiting receptor for advanced glycation end-products/nuclear factor κB signaling. |
| Q39313466 | Methylglyoxal alters glucose metabolism and increases AGEs content in C6 glioma cells |
| Q35063131 | Methylglyoxal, the dark side of glycolysis |
| Q48178370 | Methylglyoxal-induced cytotoxicity in neonatal rat brain: a role for oxidative stress and MAP kinases |
| Q38253187 | MicroRNAs are potential prognostic and therapeutic targets in diabetic osteoarthritis |
| Q27315179 | Microglial AGE-albumin is critical in promoting alcohol-induced neurodegeneration in rats and humans |
| Q35163077 | Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processes |
| Q87939347 | Modified Si-Miao-San ameliorates pancreatic B cell dysfunction by inhibition of reactive oxygen species-associated inflammation through AMP-kinase activation |
| Q48622926 | Molecular mechanisms of the antiglycative and cardioprotective activities of Psidium guajava leaves in the rat diabetic myocardium |
| Q38096444 | Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. |
| Q35165597 | Morphological Changes and Immunohistochemical Expression of RAGE and its Ligands in the Sciatic Nerve of Hyperglycemic Pig (Sus Scrofa) |
| Q36139958 | Mouse RAGE Variant 4 Is a Dominant Membrane Receptor that Does Not Shed to Generate Soluble RAGE. |
| Q37459539 | Musculoskeletal Impairments Are Often Unrecognized and Underappreciated Complications From Diabetes |
| Q35865399 | Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets. |
| Q54944546 | Networks of blood proteins in the neuroimmunology of schizophrenia. |
| Q38246170 | New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction |
| Q51186905 | Nitrite-induced cross-linking alters remodeling and mechanical properties of collagenous engineered tissues. |
| Q38700889 | Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. |
| Q37217856 | Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches |
| Q37729841 | Nutrients and the Pancreas: An Epigenetic Perspective |
| Q37261237 | Oat Protects against Diabetic Nephropathy in Rats via Attenuating Advanced Glycation End Products and Nuclear Factor Kappa B. |
| Q53066000 | Overexpression of RAGE contributes to cigarette smoke-induced nitric oxide generation in COPD. |
| Q35833994 | Oxidative stress in aging human skin |
| Q89579244 | PANEV: an R package for a pathway-based network visualization |
| Q34592806 | PPARγ activation attenuates glycated-serum induced pancreatic beta-cell dysfunction through enhancing Pdx1 and Mafa protein stability |
| Q26796268 | Parainflammation, chronic inflammation, and age-related macular degeneration |
| Q37108641 | Periodontal disease: associations with diabetes, glycemic control and complications |
| Q91949654 | Persistent organic pollutants (POPs) increase rage signaling to promote downstream cardiovascular remodeling |
| Q41880812 | Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/-mice |
| Q43685598 | Phytochemical constituents of Mongolian traditional medicinal plants, Chamaerhodos erecta and C. altaica, and its constituents prevents the extracellular matrix degradation factors |
| Q49117467 | Plasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress |
| Q35670850 | Polyphenols and human health: prevention of disease and mechanisms of action |
| Q38698313 | Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications |
| Q33608632 | Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4 |
| Q51246577 | Predictors for Gingival Index in Middle-Aged Asian Indians with Type 2 Diabetes from South India: A Cross-Sectional Observational Study. |
| Q36825616 | Protection effect of endomorphins on advanced glycation end products induced injury in endothelial cells |
| Q64099255 | Protective Effects of Kaempferol on D-Ribose-Induced Mesangial Cell Injury |
| Q43049148 | Protective role of salidroside against aging in a mouse model induced by D-galactose. |
| Q28578850 | Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress |
| Q33301686 | Proteomics in pediatric research and practice |
| Q37152947 | RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. |
| Q26744630 | RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage |
| Q60732952 | RAGE Gene Polymorphisms in Patients with Multiple Sclerosis |
| Q89484239 | RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review |
| Q37199673 | RAGE mRNA expression and its correlation with nuclear factor kappa beta mRNA expression in inflamed human periradicular tissues |
| Q33520403 | RAGE supports parathyroid hormone-induced gains in femoral trabecular bone |
| Q37384331 | Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response |
| Q37685213 | Receptor for advanced glycation end as drug targets in diabetes-induced skin lesion |
| Q38234624 | Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury |
| Q33841564 | Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease |
| Q41926813 | Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis |
| Q39397658 | Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products |
| Q54060443 | Relationship between RAGE gene polymorphisms and cardiovascular disease prognosis in the Chinese Han population. |
| Q54889072 | Relationship of shoulder activity and skin intrinsic fluorescence with low level shoulder pain and disability in people with type 2 diabetes. |
| Q90633592 | Relationships of diabetes and hyperglycaemia with intraocular pressure in a Japanese population: the JPHC-NEXT Eye Study |
| Q35896615 | Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy |
| Q27004644 | Role of methylglyoxal in Alzheimer's disease |
| Q37219745 | Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice |
| Q54311344 | Rosiglitazone modulates the behaviors of diabetic host-derived fibroblasts in a carboxymethyllysine-modified collagen model. |
| Q33595290 | Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products |
| Q37354472 | S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis |
| Q42866173 | STR/ort mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers |
| Q39015617 | Sciadopitysin alleviates methylglyoxal-mediated glycation in osteoblastic MC3T3-E1 cells by enhancing glyoxalase system and mitochondrial biogenesis |
| Q42859517 | Scopoletin from the flower buds of Magnolia fargesii inhibits protein glycation, aldose reductase, and cataractogenesis Ex Vivo |
| Q43217889 | Second generation 2-aminoimidazole based advanced glycation end product inhibitors and breakers |
| Q35601343 | Selective Inhibition on RAGE-binding AGEs Required by Bioactive Peptide Alpha-S2 Case in Protein from Goat Ethawah Breed Milk: Study of Biological Modeling |
| Q37300540 | Senescence-dependent impact of anti-RAGE antibody on endotoxemic liver failure |
| Q37663816 | Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide |
| Q51127315 | Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients. |
| Q50624062 | Severity of Type 2 Diabetes, Cognitive Function, and Self-Care. |
| Q35071085 | Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study |
| Q45090317 | Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice |
| Q51700919 | Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity. |
| Q37865409 | Special issues in the management and selection of the donor for lung transplantation |
| Q24322846 | Structural and functional insights into RAGE activation by multimeric S100B |
| Q38904883 | Sweet old memories: a review of the experimental models of the association between diabetes, senility and dementia |
| Q39018573 | Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation |
| Q36154554 | Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats |
| Q55088424 | Targeting glucose metabolism for healthy aging. |
| Q38686477 | Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective. |
| Q36970069 | The Association of -429T>C and -374T>A Polymorphisms in the RAGE Gene with Polycystic Ovary Syndrome. |
| Q37785150 | The Drosophila 7-pass transmembrane glycoprotein BOSS and metabolic regulation: What Drosophila can teach us about human energy metabolism |
| Q64240851 | The Effect of Vitamin D on Cellular Pathways of Diabetic Nephropathy |
| Q38126643 | The Maillard reaction and pet food processing: effects on nutritive value and pet health. |
| Q49169179 | The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy. |
| Q37444372 | The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence |
| Q42226832 | The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications |
| Q36132723 | The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation |
| Q46569717 | The anti-hepatic fibrosis activity of ergosterol depended on upregulation of PPARgamma in HSC-T6 cells |
| Q33615012 | The attenuation of Moutan Cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats |
| Q36787569 | The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications |
| Q34644417 | The biology of aging and frailty |
| Q35617622 | The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1. |
| Q33278821 | The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function |
| Q48951906 | The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells |
| Q36454454 | The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer's disease pathogenesis |
| Q39678954 | The novel function of advanced glycation end products in regulation of MMP-9 production |
| Q38025026 | The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome |
| Q59329530 | The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review |
| Q39394561 | The role of receptor for advanced glycation end products (RAGE) in neuronal differentiation |
| Q35160764 | The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes. |
| Q37254561 | The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. |
| Q92343798 | Therapeutic Potential of Lespedeza bicolor to Prevent Methylglyoxal-Induced Glucotoxicity in Familiar Diabetic Nephropathy |
| Q51487967 | Toxicological evaluation of advanced glycation end product Nε-(carboxymethyl)lysine: Acute and subacute oral toxicity studies. |
| Q35859768 | Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging. |
| Q92635133 | UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease |
| Q43521840 | Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma |
| Q36860811 | Update on the protective molecular pathways improving pancreatic beta-cell dysfunction |
| Q36514906 | Uremic Toxicity of Advanced Glycation End Products in CKD. |
| Q46044501 | Vascular biomarkers in the metabolic syndrome |
| Q37636453 | Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms |
| Q28393488 | Vibrational spectroscopic imaging for the evaluation of matrix and mineral chemistry |
| Q39220959 | Vibrational spectroscopic techniques to assess bone quality |
| Q64973366 | Vitamin D suppresses cellular pathways of diabetes complication in liver. |
| Q83130963 | [The influence of diabetes mellitus on male reproductive function: a poorly investigated aspect of male infertility] |
| Q38792762 | miR-223 contributes to the AGE-promoted apoptosis via down-regulating insulin-like growth factor 1 receptor in osteoblasts |
| Q54979238 | miR-5591-5p regulates the effect of ADSCs in repairing diabetic wound via targeting AGEs/AGER/JNK signaling axis. |
| Q36867450 | sRAGE and risk of diabetes, cardiovascular disease, and death |
| Q35777756 | siRNA Screening Identifies the Host Hexokinase 2 (HK2) Gene as an Important Hypoxia-Inducible Transcription Factor 1 (HIF-1) Target Gene in Toxoplasma gondii-Infected Cells |
| Q35056697 | wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early death |
Search more.